BMEA - Biomea Fusion, Inc.

QQQ $ 626.40 $ 7.95 (1.29 %)

DIA $ 473.66 $ 2.77 (0.59 %)

SPY $ 680.41 $ 5.37 (0.8 %)

TLT $ 88.99 $ -0.53 (-0.59 %)

GLD $ 366.61 $ 0.17 (0.05 %)

Previous Close

$ 1.26

Open

$ 1.26

Bid

$ 1.33 x 250

Ask

$ 1.34 x 334

Day's Range

$ 1.23 - $ 1.34

52 Week Range

$ 1.24 - $ 9.34

Volume

1,219,201

Average Volume

Market Cap

89.09M

Beta (5Y Monthly)

$ 0.49

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-05-2025	06-30-2025	10-Q
3	05-05-2025	03-31-2025	10-Q
4	03-31-2025	12-31-2024	10-K
5	10-29-2024	09-30-2024	10-Q
6	07-31-2024	06-30-2024	10-Q
7	05-02-2024	03-31-2024	10-Q
8	03-28-2024	12-31-2023	10-K
9	10-30-2023	09-30-2023	10-Q
10	07-31-2023	06-30-2023	10-Q
11	05-02-2023	03-31-2023	10-Q
12	03-28-2023	12-31-2022	10-K
13	11-07-2022	09-30-2022	10-Q
14	08-01-2022	06-30-2022	10-Q
15	05-16-2022	03-31-2022	10-Q
16	02-28-2022	12-31-2021	10-K
17	11-03-2021	09-30-2021	10-Q
18	08-11-2021	06-30-2021	10-Q
19	05-27-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

D. Boral Capital Maintains Buy on Biomea F...
11/05/2025 13:39:26

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $16...

Biomea Fusion Presents Preclinical Data Fo...
11/05/2025 12:17:56

Biomea Fusion, Inc. ("Biomea," "Biomea Fusion" or the "Company") (Nasdaq: BMEA), a clinical-stage diabe...

Biomea Fusion Q3 EPS $(0.27) Misses $(0.26...
11/04/2025 21:46:45

Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.2...

D. Boral Capital Maintains Buy on Biomea F...
10/27/2025 12:40:40

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

Biomea Fusion Doses First Patient In Phase...
10/27/2025 12:12:26

12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 17:06:17

nasdaq-tumbles-200-points-trilogy-metals-shares-spike-higher

Nasdaq Tumbles 200 Points; Trilogy Metals ...
10/07/2025 16:29:00

biomea-fusion-stock-plummets-following-public-offering-diabetes-study

Biomea Fusion Stock Plummets Following Pub...
10/07/2025 14:35:35

Biomea Fusion reported favorable safety for icovamenib in a 52-week diabetes study, alongside a $25 million public offering.

dow-jumps-over-100-points-mccormick-earnings-top-views

Dow Jumps Over 100 Points; McCormick Earni...
10/07/2025 14:20:36

12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 12:08:21

Biomea Fusion Announces Pricing Of Its Und...
10/07/2025 12:05:48

Biomea Fusion, Inc. ("Biomea") (NASDAQ:BMEA), a clinical-stage diabetes and obesity company, today announced the pricin...

12 Health Care Stocks Moving In Monday's A...
10/06/2025 21:06:27

Biomea Fusion Announces Proposed Public Of...
10/06/2025 20:18:41

Biomea Fusion, Inc. ("Biomea") (NASDAQ:BMEA), a clinical-stage diabetes and obesity company, announced today that it ha...

Biomea Fusion Announces 52-Week Phase II D...
10/06/2025 20:04:28

Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient...

D. Boral Capital Maintains Buy on Biomea F...
10/03/2025 12:32:26

D. Boral Capital analyst Jason Kolbert maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $16 price target.

Biomea Fusion Presents Data Showing Icovam...
09/16/2025 11:17:19

this-oddity-tech-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

This Oddity Tech Analyst Begins Coverage O...
08/28/2025 12:43:21

Jefferies Initiates Coverage On Biomea Fus...
08/28/2025 12:31:06

Jefferies analyst Roger Song initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target ...

Citigroup Maintains Buy on Biomea Fusion, ...
08/11/2025 13:13:35

Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $9 to $7.

Scotiabank Maintains Sector Outperform on ...
08/06/2025 16:27:44

Scotiabank analyst George Farmer maintains Biomea Fusion (NASDAQ:BMEA) with a Sector Outperform and lowers the price target ...